ZH
RU
ES

immune cell disease

immune cell disease, Total:25 items.

In the international standard classification, immune cell disease involves: Veterinary medicine, Farming and forestry, Pharmaceutics, Vocabularies, Medical sciences and health care facilities in general, Laboratory medicine.

Association Francaise de Normalisation, immune cell disease

• NF U47-221:2010 Isolation on cell culture and identification by immunofluorescence of infectious haematopoietic necrosis virus of fish.
• NF U47-220:2010 Isolement sur culture cellulaire et identification par immunofluorescence du virus de la septicémie hémorragique virale des poissons
• NF U47-027:2021 Méthodes d'analyse en santé animale - Recherche d'anticorps contre la maladie des muqueuses par la technique de neutralisation virale et immunochimie sur culture cellulaire (IF ou IP)

Professional Standard - Agriculture, immune cell disease

• 1259药典 化学药和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs against Human T Cell Immunoglobulin
• 1258药典 化学药和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs Anti-Human T Cell CD3 Mouse Monoclonal Antibody
• 259药典 三部-2010 Appendix Ⅹ XR Anti-human T cell immunoglobulin titer assay (lymphocytotoxicity test)
• 124药典 三部-2020 Monograph Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
• 125药典 三部-2020 Monograph Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulins
• 113药典 三部-2015 Monograph Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
• 114药典 三部-2015 Monograph Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulins
• 92药典 三部-2010 Chapter Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulin
• 91药典 三部-2010 Chapter Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
• 1264药典 化学药和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 2. Immunoenhancing Drugs Pseudomonas
• 1252药典 化学药和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs Rat Anti-Human T Lymphocyte CD3 Antigen Monoclonal Antibody

Group Standards of the People's Republic of China, immune cell disease

• T/CGCPU 010-2020 Environmental requirements for the preparation of immune cell products
• T/CGCPU 011-2020 Quality Control Requirements for Immune Cell Products
• T/CGCPU 009-2020 Control requirements for the preparation process of immune cell products
• T/CGCPU 019-2022 Material management requirements for immune cell product donors
• T/XSMIA 0004-2022 Quality Accreditation of Immunocyte Preparation Center
• T/CGCPU 018-2022 Technical requirements for CD3, CD4, CD8 flow cytometric detection and verification of immune cell products
• T/GDMDMA 0001-2022 Interleukin 6 Detection kit (Chemiluminescent Immunoassay)

Hebei Provincial Standard of the People's Republic of China, immune cell disease

• DB13/T 5332-2021 Technical specification for clinical operation of cellular immunotherapy

Professional Standard - Aquaculture, immune cell disease

• SC 7701-2007 Cell cultured inactivated vaccine against hemorrhagic disease of grass carp

American Society for Testing and Materials (ASTM), immune cell disease

• ASTM F1906-98(2003) Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration

Professional Standard - Commodity Inspection, immune cell disease

• SN/T 4291-2015 Technical specification for simian immunodeficiency virus dot enzyme immuno-quarantine

Others:   cellular immunity, Immune Cells, cellular immunity, Immune Cells, immune cells, cellular immune cells, red blood cell disease, immune disease, cell disease, immune cell disease, +immune cells, virus disease immunity, immune cell disease, virus disease immunity, immune response immune cells, immune cells, immune cells, cellular immune cells, immune cell immune response, Immunity | Cellular Immunity.